CBS vous accompagne

Nos adhérents

Newsletter CBS

Recevez votre lettre d'information

Participez à la Rencontre Immunothérapies ciblées des cancers et maladies inflammatoires à Montpellier

28 mars 2019

 

 EUROBIOMED presents: key advances and future promises in immunotherapy antibodies and cellular therapies for the treatment of cancers and inflammatory diseases.

Over the last years, immunotherapies have shown very good results notably with the last generation of treatments combining different approaches for the treatment of melanoma and NSCLC. But despite the success and hope, these treatments generate severe adverse reactions, a high proportion of people still do not respond to immunotherapy, and their use in some pathologies are still in the preclinical phase. Lots of efforts are made in order to increase efficacy with new targets, new formats, combination of treatments and with the development of cellular therapies targeting the immune system. All these aspects will be addressed during this one day symposium and we will benefit from the point of view of the French pharmaceutical industry.


Thursday 28th of March 2019 in Montpellier - 8h30 - Sanofi Montpellier Headquarters

(371 Rue du Professeur Blayac, 34080 Montpellier - Map)

Program

8h30

Registration and Coffee
 

9h00

Welcome words and Eurobiomed presentation
- Emilie Royere, General Director Eurobiomed
 

9h20

Opening Lecture
- Name to be confirmed

 

10h00

The next generation of immunotherapy to increase efficacy (Part I)
- Dr. Jean-Jacques Fournié (CRCT - Toulouse)
- M. René Hoet (Imcheck Therapeutics - Marseille)
 

10h40

Coffee Break
 

11h00

The next generation of immunotherapy to increase efficacy (Part II)
- Dr. Julien Faget (IRCM - MabImprove - Montpellier)
- M. Nicolas Poirier (Ose Immunotherapeutics - Nantes)
- Dr. Bruno Ségui (CRCT - Toulouse)

- M. Hatem Azim (Innate Pharma - Marseille)

12h20

Lunch and networking
 

13h40

Afternoon Lecture
- Prof. Christian Chabannon (CTCG, IPC - AP-HM - Marseille)
 

14h20

New cellular and genetic approaches to treat diseases
- Dr. Martin Villalba (IRMB - Montpellier)
- Mrs. Pascale Bouillé (Flash Therapeutics - Toulouse)
- Dr. Julio Delgado (Hospital Clinic Barcelona)

- Mrs. Caroline Courme (Sangamo - Nice)


15h40

Coffee Break

16h00

The pharmaceutical industry's point of view
Sanofi, Servier and Pierre Fabre will be present

17h00

Conference closing

  Chairmen: Prof. John De Vos (IRMB - Montpellier) and Prof. Pierre Martineau (IRCM - Montpellier).


Register before the 28th of March 2019

Inscrivez-vous en ligne

Information :

Nicolas REYMOND: nicolas.reymond(at)eurobiomed.org

 


 The is event is organized with the support of:


 
 
   
In partnership with:
     


Tout l'agenda